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Molecular Analysis of Collagen XVIII Reveals Novel Mutations,
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Knobloch syndrome (KS) is a rare disease characterized by severe ocular alterations, including vitreoretinal degen-
eration associated with retinal detachment and occipital scalp defect. The responsible gene, COL18A1, has been
mapped to 21q22.3, and, on the basis of the analysis of one family, we have demonstrated that a mutation affecting
only one of the three COL18A1 isoforms causes this phenotype. We report here the results of the screening of both
the entire coding region and the exon-intron boundaries of the COL18A1 gene (which includes 43 exons), in eight
unrelated patients with KS. Besides 20 polymorphic changes, we identified 6 different pathogenic changes in both
alleles of five unrelated patients with KS (three compound heterozygotes and two homozygotes). All are truncating
mutations leading to deficiency of one or all collagen XVIII isoforms and endostatin. We have verified that, in exon
41, the deletion c3514-3515delCT, found in three unrelated alleles, is embedded in different haplotypes, suggesting
that this mutation has occurred more than once. In addition, our results provide evidence of nonallelic genetic
heterogeneity in KS. We also show that the longest human isoform (NC11-728) is expressed in several tissues
(including the human eye) and that lack of either the short variant or all of the collagen XVIII isoforms causes
similar phenotypes but that those patients who lack all forms present more-severe ocular alterations. Despite the
small sample size, we found low endostatin plasma levels in those patients with mutations leading to deficiency of
all isoforms; in addition, it seems that absence of all collagen XVIII isoforms causes predisposition to epilepsy.
Introduction
Knobloch syndrome (KS [MIM 267750]) is an autosomal
recessive disorder characterized by high myopia, vitreo-
retinal degeneration with retinal detachment, macular
abnormalities, and occipital encephalocele. Clinical var-
iability is present, but all patients have ocular abnor-
malities that usually lead to bilateral blindness. The oc-
cipital encephalocele is a major clinical feature that has
been described in 22 of 24 reported cases (Knobloch and
Layer 1971; Czeizel et al. 1992; Seaver et al. 1993; Pas-
sos-Bueno et al. 1994; Wilson et al. 1998; Sniderman et
al. 2000). Other minor clinical abnormalities—such as
lens subluxation, cataracts, hypoplasia of the right lung
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with anomalous pulmonary return, cardiac dextrover-
sion, flat nasal bridge, midface hypoplasia, bilateral epi-
canthic folds, generalized hyperextensibility of the joints,
unilateral duplicated renal collecting system, and unusual
palmar creases—have been observed in single families
(Knobloch and Layer 1971; Czeizel et al. 1992; Seaver et
al. 1993; Passos-Bueno et al. 1994; Wilson et al. 1998).
Recently, a patient with midline frontal-region scalp defect
associated with high myopia, vitreoretinal degeneration,
and abnormal macular pigmentation had a diagnosis of
KS (Sniderman et al. 2000). It is still unclear whether all
of these features are part of the clinical spectrum of KS.
KS seems to be a rare condition, with only 24 patients
from six unrelated families having been reported to date
(Knobloch and Layer 1971; Czeizel et al. 1992; Seaver
et al. 1993; Passos-Bueno et al. 1994; Wilson et al. 1998;
Sniderman et al. 2000). On the basis of the study of a
single large, inbred Brazilian family with 12 individuals
affected with KS, we previously mapped the disease gene
to 21q22.3 and demonstrated that a homozygous mu-
tation (IVS1-2ArT) at the AG consensus acceptor splice
site of COL18A1 intron 1 causes KS (Sertie´ et al. 2000).
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Figure 1 Diagram of the N-terminal region of COL18A1, showing the two distinct promoters and the alternate transcription start sites
The COL18A1 gene includes 43 exons and is reported
to encode two distinct isoforms in humans by use of two
promoters, one of which is located upstream from exon
1 and the other of which is located upstream from exon
3. Use of the upstream promoter yields a product that
contains exons 1 and 2 but excludes exon 3, whereas the
product of the downstream promoter starts in exon 3
(Saarela et al. 1998b) (fig. 1). Therefore, these two iso-
forms differ only at their signal peptides, with variant
N-terminal noncollagenous domains (“NC11’s,” accord-
ing to the nomenclature outlined by Oh et al. [1994a,
1994b]) that are 303 (short variant; NC11-303) and
493 (median variant; NC11-493) residues in length. In
the mouse orthologue gene, the variant NC11-764, cor-
responding to a third collagen XVIII isoform, which has
not yet been fully characterized in humans, is also tran-
scribed from the promoter in intron 2 but differs from
the mouse NC11-517 (comparable to the human NC11-
493) by the inclusion of the entire third exon (Oh et al.
1994a; Saarela et al. 1998a, 1998b). Collagen XVIII was
shown, by sequence analysis, to consist of a central, in-
terrupted triple-helical domain and to be flanked at the
N-terminus (NC11 domain) and the C-terminus (NC1
domain) by larger non–triple-helical, presumably glob-
ular structures (Oh et al. 1994a, 1994b; Rehn and Pih-
lajaniemi 1994). A 20-kDa proteolytic cleavage product,
endostatin, is derived from its C-terminal NC1 domain.
Endostatin can inhibit angiogenesis and can decrease en-
dothelial cell migration and proliferation (O’Reilly et al.
1997). It has also been found to have an effect on ap-
optosis and migration of other cell types, including neu-
rons and renal epithelial cells (Ackley et al. 2001; Lin et
al. 2001). The formation of collagen XVIII homotrimers
is probably controlled by a 50-residue region within the
NC1 domain (Sasaki et al. 1998). This collagen was
shown to be expressed in a large number of tissues, to
be localized in vessel walls and almost all basement mem-
branes by using antibodies against NC11 domains, and
to have some differences in the expression of each isoform
in different tissues (Saarela et al. 1998a, 1998b). The
NC11-493 mRNA variant is mainly expressed in fetal
and adult liver, whereas the NC11-303 variant was found
at the highest levels in the fetal and adult kidney (Saarela
et al. 1998a, 1998b). This short isoform is also expressed
in human retina and fetal brain, which are the tissues
almost invariably affected in patients with KS (Sertie´ et
al. 2000). In contrast, in human tissues, the expression
of the human counterpart of the mouse NC11-764 var-
iant (predicted to be NC11-728) has not been described.
The mutation at the acceptor splice site of COL18A1
intron 1 (i.e., IVS1-2ArT, identified in the original fam-
ily that we studied) abolished the function of only the
short variant (NC11-303) of collagen XVIII. Therefore,
the characterization of COL18A1 mutations in other
patients with KS, including those with atypical phe-
notypes, will be important to ascertain whether muta-
tions in other regions of the gene cause a similar phe-
notype, to assess for genetic heterogeneity, and, finally,
to better define the spectrum of clinical variability in
this syndrome. In the present article, we have also eval-
uated the expression pattern of the NC11-728 variant
(the counterpart for the mouse NC11-764 variant) in
several human tissues.
Subjects, Material, and Methods
Subjects
Eight unrelated families with patients who had a
diagnosis of KS were referred to our center (Centro
de Estudos do Genoma Humano) at the University of
Sa˜o Paulo; four of these families were Brazilian (KS2,
KS3, KS8, and KS9), two were North American (KS4
and KS5), one was Hungarian (KS6), and one was of
Canadian-Haitian origin (KS7). The clinical descrip-
tion of the last two families has been reported else-
where (Czeizel et al. 1992; Sniderman et al. 2000),
and the six other families are described here for the
first time. These patients present occipital encephalo-
cele and the typical ocular alterations described in
patients with KS; no other major malformation was
observed. Five families (KS2, KS4, KS6, KS8, and KS9)
represented familial cases, and the other three (KS3, KS5,
and KS7) represented sporadic cases. Consanguinity was
observed in three genealogies (KS2, KS8, and KS9).
DNA Extraction
Blood was drawn after written informed consent was
obtained, and DNA was extracted using a standard pro-
cedure (Miller et al. 1988).
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Mutation Analysis of the COL18A1 Gene
We amplified each of the 43 exons of the COL18A1
gene through PCR in seven of the eight propositi. In one
case, the DNA from the patient (KS6) ran out, and we
analyzed all the coding sequence and the exon-intron
borders of the DNA from his parents, except for exon
1 of the patient’s father. The primer-pair sequences used
are available in table A (online only). Each exon was
screened for mutations through bidirectional sequenc-
ing, which was performed with the same primers that
were used for PCR amplification and with DyeDeoxy
Terminator Cycle Sequencing Ready Reaction Kit (Ap-
plied Biosystems), according to the ABI standard pro-
tocol. The PCR products were purified with exonuclease
I and shrimp alkaline phosphatase (0.5 U/ml of PCR
product) or with QIAquick PCR Purification Kit (Qia-
gen). Sequences were analyzed in an ABI 377 automated
DNA sequencer.
The characterization of a mutation as pathogenic or
polymorphic was based on the analysis of the change
within a family and/or within 100 control chromosomes.
The nomenclature of the mutations follows that outlined
by Antonarakis et al. (1998), and we have used the
cDNA numbering of the isoform NC11-303 (GenBank
accession number AF018082) starting from the first
ATG (gene sequence can be found at position chr21:
43334766-43443318 of the draft human genome; June
2002 freeze [Human Genome Browser Gateway]).
Haplotype Analysis
We determined the haplotype of the 21q region, to
characterize the origin of a recurrent mutation, as well
as to verify whether affected sibs share the same 21q at-
risk region. The following markers were used: three in-
tragenic polymorphic markers (dbSNP IDs rs2236451,
rs2236474, and rs7499) and COL18A1/3′ UTR, as well
as microsatellites D21S1897, D21S171, 61.300, 139.000,
and 179.500 (proximal to COL18A1) and D21S1446
(distal to COL18A1).
The microsatellites were analyzed by PCR, which was
performed in a total volume of 10 ml (containing 40–60
ng of genomic DNA; 2.5 pmol of each primer; 200 mM
dATP, dTTP, and dGTP; 2.5 mM dCTP; 7.5# 104 mCi
[a-32P] dCTP; 10 mM Tris-HCl [pH 9.0]; 50 mM KCl;
1.5 mM MgCl2; 0.01% gelatin; 0.1% Triton; and 0.1
U Taq DNA polymerase). The thermocycling conditions
used for amplification consisted of 28 cycles at 94C for
30 s, 55C for 30 s, and 72C for 30 s.
The COL18A1/3′-UTR polymorphism was analyzed
by PCR and SSCP analysis, according to instructions
published elsewhere (Sertie´ et al. 1999).
RT-PCR Analysis of the NC11-728 Isoform
Total RNA was purified from adult lymphocytes,
retina, and cultured skin fibroblasts by the guanidium
isothiocyanate method (Chomczynski and Sacchi 1987).
Fetal-brain RNA was purchased from Research Genet-
ics, and adult-liver and adult-kidney total RNA was pur-
chased from Clontech. RT-PCR was performed with to-
tal RNA (1 mg) from each tissue by using the OneStep
Reverse Transcriptase systems (Life Technologies). The
following pair of primers was used: 5′-CCAGGAGGAT-
GGGTACTGTG-3′ and 5′-AGTCACGGAAGAAGAG-
GCTG-3′.
The design of these primers was based on the exon
structure of the mouse NC11-764 (GenBank accession
number AH006757), and they specifically amplify this
isoform. RT-PCR products were sequenced in both di-
rections by using the same primers.
Endostatin Plasma Levels
Endostatin plasma concentrations were measured
through ELISA. Plasma for endostatin measurements was
immediately separated after the drawing of the blood and
was frozen at70C. We were able to obtain 23 samples,
for endostatin plasma measurements, from members of
six families—11 patients (3 from family KS1, 1 from KS2,
1 from KS5, 1 from KS7, 3 from KS8, and 2 from KS9)
and 12 unaffected individuals (4 from family KS1, 2 from
KS5, 2 from KS7, 2 from KS8, and 2 from KS9). Family
KS1 includes 12 affected individuals and has been de-
scribed elsewhere (Sertie´ et al. 2000). ELISA for plasma
endostatin was performed using a commercially available
assay (Accucyte; Cytimmune Sciences), according to the
manufacturer’s instructions. All measurements were per-
formed in duplicate, to ensure the accuracy of the data
collected. The kit used has a sensitivity of 1.95 ng/ml and
has typical inter- and intra-assay variances of10%. The
normal values of plasma endostatin in the population
that we studied have been estimated as ng/20.3 11.5
ml (Zorick et al. 2001).
Results
Phenotype and Identification of Pathogenic Mutations
The main clinical features of the patients from the
eight unrelated families are summarized in table 1. Note
that patient KS7, previously described by Sniderman et
al. (2000), does not present a typical phenotype of KS.
In the eight propositi, sequencing analysis of the
COL18A1 gene revealed 20 changes that were con-
sidered to be polymorphic because they occurred with
a frequency 11% in control chromosomes. All of these
polymorphic changes have been described elsewhere
(Iughetti et al. 2001). In five unrelated propositi (table
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Table 2
Pathogenic Mutations
Patienta Mutation(s) (cDNA change) Region(s) Consequence(s) Affected isoforms
KS1b IVS1-2ArT (homozygous) Intron 1 Splicing—stop codon at 4 Only short form
KS2 No mutation detected … … …
KS3 c2969-2978delCAGGGCCCCC (maternal),
c3514-3515delCT (paternal)
Exon 36,
exon 41
Frameshift—stop codon at 38;
frameshift—stop codon at 42
All isoforms
KS4 c1238-1239insA (maternal),
c3514-3515delCT (paternal)
Exon 10,
exon 41
Frameshift—stop codon at 13;
frameshift—stop codon at 42
All isoforms
KS5 c3514-3515delCT (maternal),
c2105delC (paternal)
Exon 23,
exon 41
Frameshift—stop codon at 24;
frameshift—stop codon at 42
All isoforms
KS6c No mutation detected … … …
KS7 No mutation detected … … …
KS8 IVS1-2ArT (homozygous) Intron 1 Splicing—stop codon at 4 Only short form
KS9 c3277CrT (homozygous) Exon 40 Premature stop codon (Q1093X) All isoforms
a For each family, there is only one propositus.
b Previously reported by Sertie´ et al. (2000).
c First exon was not analyzed.
2), we identified the causative mutation in both alleles:
three were compound heterozygotes, and two were
homozygotes. One change, a deletion of CT in exon
41 (c3514-3515delCT), was observed in three unre-
lated alleles (in families KS3, KS4, and KS5). The five
other mutations were an insertion of 1 bp in exon 10
(c1238-1239insA; KS4), a deletion of 1 bp in exon
23 (c2105delC; KS5), a deletion of 10 bp in exon 36
(c2969-2978delCAGGGCCCCC; KS3), a nonsense mu-
tation in exon 40 (c3277CrT; KS9), and a mutation at
the acceptor splice site of intron 1 (IVS1-2ArT; KS8).
None of these mutations were detected in a 100-chro-
mosome control sample. We analyzed both parents of
the propositi from each family and verified that all of
them were heterozygous for one of the mutations present
in their affected descendants.
Haplotype Analysis
We compared the haplotypes of the alleles carrying
the mutation c3514-3515delCT in families KS3, KS4,
and KS5. We observed a different haplotype associated
with this common pathogenic allele, with no evidence
of a founder effect (fig. 2A).
We have also compared the haplotypes from families
KS8 and KS1 (Sertie´ et al. 2000), because they also share
a common pathogenic mutation in homozygosis (IVS1-
2ArT). In this case, we observed a common haplotype
(fig. 2B).
Patients without Detectable Pathogenic Mutation
In two patients, we did not detect any pathogenic
change after sequencing the entire coding region: one
patient (KS7) represents an isolated case (Sniderman et
al. 2000), and the other patient (KS2) has an affected
sib and unaffected parents. In still another familial case
(in family KS6; Czeizel et al. 1992), with two affected
sibs, we did not detect any pathogenic change in the
mother and in any of the 42 exons of the father; there-
fore, we included this patient in this subgroup represen-
tative of cases without a detectable pathogenic change.
Segregation analysis with polymorphic markers flanking
or within COL18A1 showed that each pair of sibs (KS2
and KS6) shares a common haplotype for this 21q22.3
region (fig. 2C).
Endostatin Measurements
The plasma endostatin levels in the affected patients
and in unaffected individuals are summarized in table
3. The plasma endostatin level of individuals homozy-
gous and heterozygous for the IVS1-2ArT mutation
were similar and were within the range observed in the
control population. Endostatin plasma levels compara-
ble to the control individuals were also observed for two
patients (KS2 and KS7) in whom we did not detect any
pathogenic change. Levels in the lower range of the con-
trol population, !10 ng/ml (Zorick et al. 2001), were
observed in the three patients with null mutations (KS5,
KS9-1, and KS9-2), in three carriers of null mutations
(the parents of patient KS5 and the mother of patient
KS9), and in the unaffected mother of patient KS7.
Expression Studies of Variant COL18A1 mRNAs
We detected the expression of the variant that corre-
sponds to the mouse isoform NC11-764 in fetal brain,
liver, kidney, retina, and fibroblasts (fig. 3). If we assume
that this third isoform is transcribed similarly in mice and
humans, then we predict that the N-terminal domain of
this human isoform has 728 residues (NC11-728), in-
cluding 235 residues encoded by the usage of the external
donor splice site in exon 3 (fig. 1).
Figure 2 Haplotype for families with KS. a, Patients from three unrelated families (KS3, KS4, and KS5), sharing the allele c3514-3515delCT.
Asterisks denote the haplotypes harboring the allele c3514-3515delCT. b, Patients from two unrelated families, homozygous for IVS1-2ArT.
c, Familial cases in which no pathogenic change was detected in the patients.
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Table 3
Endostatin Levels in Individuals from Families with KS
Family/Patient
Number Clinical Status Genotype
Endostatin Levels
(ng/ml)
KS1-1 Affected IVS1-2ArT/IVS1-2ArT 19.4
KS1-2 Affected IVS1-2ArT/IVS1-2ArT 25.5
KS1-3 Normal homozygote Wild type/wild type 22.5
KS1-4 Mutation carrier IVS1-2ArT/wild type 22.8
KS1-5 Mutation carrier IVS1-2ArT/wild type 30.9
KS1-6 Affected IVS1-2ArT/IVS1-2ArT 18.2
KS1-7 Normal homozygote Wild type/wild type 21.7
KS2-2 Affected No mutation detected 17.1
KS5-1 Affected c3514-3515delCT/c2105delC 8.5
KS5-2 Mutation carrier c3514-3515delCT/wild type 9.0
KS5-3 Mutation carrier c2105delC/wild type 9.5
KS7-1 Affected No mutation detected 26.9
KS7-2 Heterozygousa No mutation detected 8.7
KS7-3 Heterozygousa No mutation detected 17.3
KS8-1 Affected IVS1-2ArT/IVS1-2ArT 29.3
KS8-2 Affected IVS1-2ArT/IVS1-2ArT 32.7
KS8-3 Affected IVS1-2ArT/IVS1-2ArT 21.0
KS8-4 Mutation carrier IVS1-2ArT/wild type 17.9
KS8-5 Mutation carrier IVS1-2ArT/wild type 29.3
KS9-1 Affected c3277CrT/c3277CrT 7.1
KS9-2 Affected c3277CT/c3277CrT 6.7
KS9-3 Mutation carrier c3277CrT/wild type 18.4
KS9-4 Mutation carrier c3277CrT/wild type 9.8
a Uncertain status (because the diagnosis in KS7 is under discussion).
Discussion
Identification of Polymorphic and Pathogenic
Mutations
The analysis of the coding sequence of COL18A1
allowed us to identify 20 polymorphic and 6 pathogen-
ic changes. Of the polymorphic alterations, one, D104N
(within exon 42, the coding region for endostatin), was
found to be associated with predisposition to human
prostate cancer (Iughetti et al. 2001); all of the other
polymorphic alterations were located in intronic regions
or did not change the amino acid residue.
The identification of four frameshift changes, one pre-
mature termination, and one splicing mutation in the
patients studied confirms that alterations in COL18A1
cause KS. Except for the splice change IVS1-2ArT, pre-
viously reported in another family in our original publi-
cation (Sertie´ et al. 2000), all of the other mutations are
novel alterations. The frameshift mutations were located
in different regions of the gene (exons 10, 23, 36, 40,
and 41) and lead to creation of premature stop codons
in exons 13, 24, 38, 40, and 42, respectively. Therefore,
all changes probably result in RNA instability (Mendell
and Dietz 2001).
The splice change IVS1-2ArT, seen in two Brazilian
families (KS1 and KS8), has the same haplotype in the
COL18A1 region, consistent with common ancestry. The
deletion c3514-3515delCT, found in three unrelated pa-
tients from different populations (two North American
and one Brazilian), is embedded in distinct haplotypes at
the 21q22.3 region. These findings suggest that this re-
current CT deletion in exon 41 may represent a hotspot
site for mutation. We did not identify any sequence motif
that could explain a higher mutation rate in this region.
Endostatin Measurements in Patients with KS
and Their Relatives
We observed a wide range of variability of endostatin
plasma levels in patients with KS and their relatives, in
accordance with the distribution previously obtained in
the control population. The nonzero endostatin plasma
levels (!1 SD of the mean or !10 ng/ml) found in the
three affected individuals with null mutations were un-
expected, since this molecule was absent in mice with
null mutations in collagen XVIII (Fukai et al. 2002).
One possible explanation for these discrepancies is the
different pathogenic mutational mechanisms involved in
each case; alternatively, but less probably, these might
be caused by the presence of a cross-reacting molecule,
perhaps endostatin derived from the C-terminal region
of collagen XV. Endostatin plasma levels should be mea-
sured in a larger sample of patients with KS, but the
present data do not encourage the use of endostatin
plasma levels as a tool for the diagnosis of this syndrome.
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Figure 3 RT-PCR using primers for the human NC11-728 COL18A1 variant mRNA (208 bp) in different human tissues. Lane a, NC11-
728. Lane b, b-actin (250 bp), used as positive control. Lane c, NC11-728 together with b-actin.
Patients without a Detectable Pathogenic Mutation
We were not able to find pathogenic mutations in the
coding region in patients from three unrelated families;
one (KS7) represented an isolated case, and the two oth-
ers (KS2 and KS6) represented familial cases. Patient KS7
had some ocular alterations that are comparable to those
of KS, but he presented several other clinical features
(including a scalp defect in the frontal region, devel-
opmental delay, telecanthus, hypertelorism, and high-
arched palate) that are not typical of this syndrome. On
the basis of the atypical clinical features, we suggest that
his phenotype is probably caused by mutations at an-
other locus, and we emphasize that the location of the
scalp defect in the occipital region is specific to KS. Men-
zel et al. (2000) reported discordant 21q22.3 haplotypes
in two affected sibs with clinical features of KS, further
supporting genetic heterogeneity of this syndrome. In
contrast, the patients from the two other families (KS2
and KS6) present both the ocular and occipital defects
that are typical of KS; besides, the two affected sibs from
each genealogy share a common 21q22.3 region, in
agreement with linkage between theCOL18A1 gene and
KS. The lack of detectable pathogenic mutation was un-
expected, and it is possible that the phenotype in these
patients is caused by a different COL18A1 mutational
mechanism that was not detected by the methods used
here. Despite the evidence from the linkage studies, we
cannot discard the possibility of nonallelic genetic het-
erogeneity in these patients.
Genotype-Phenotype Correlation
The phenotype of all patients with an identified path-
ogenic change in COL18A1 is very characteristic of KS,
with occipital scalp defect and severe ocular alterations
from birth. Variability in the size of the occipital alteration
was observed within and among the different families and
does not seem to be associated with the lack of one or
all collagen XVIII isoforms. Note that the knockout mice
for Col18a1 do not present this cranial alteration (Fukai
et al. 2002).
The premature stop codons in exons 13, 24, 38, 40,
and 42 possibly lead to lack of all isoforms ofCOL18A1
and endostatin; this lack may be due to mRNA or pro-
tein instability (Mendell and Dietz 2001). Interestingly,
a frameshift deletion within the C-terminal region of the
Cle1 gene, the homologue of COL18A1 in Caenorhab-
ditis elegans, is associated with a stable product (Ackley
et al. 2001).
All seven of the patients from family KS1 who are
known to be blind lost their vision after 20 years of age
(data not shown). In contrast, we have observed that
most patients with mutations that are predicted to cause
deficiency of all collagen isoforms are going blind early,
in childhood, suggesting that deficiencies of all collagen
XVIII forms are associated with a worse ocular prog-
nosis. The human collagen NC11-303 and NC11-493
variants are highly expressed in kidney and liver (Saarela
et al. 1998b), and we have recently described the pres-
ence of the NC11-303 form but not the NC11-493 form
in human retina (Sertie´ et al. 2000). In the present article,
we show that the longest human isoform, NC11-728,
containing the cysteine-rich frizzled motif, is expressed
in the human eye and in other tissues, including liver,
as has previously been observed in mice (Muragaki et
al. 1995; Rehn and Pihlajaniemi 1995). On the basis of
these findings and the apparently more severe clinical
course of the eye abnormalities, we suggest that the short
isoform (NC11-303) is critical for the maintenance of
retinal and eye structure and for the correct closure of
the neural tube at the occipital region, but the long iso-
form (NC11-728) should also play a critical role in the
organization and maintenance of the human eye.
We initially hypothesized that the ocular alterations
in KS could be related to a deficiency of retinal vascu-
larization and a structural defect in the vitreous humor
and retina (Sertie´ et al. 2000). Indeed, ∼80% of mice
lacking collagen XVIII and endostatin show abnormal
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retinal vessels, probably due to a delayed regression of
blood vessels in the vitreous humor, along the surface of
the retina after birth; in addition, a reduced number of
vitreous collagen fibers were observed along the inner
limiting membrane in Col18a1/ mice eyes (Fukai et
al. 2002).
None of the patients with mutations in the COL18A1
gene have any major kidney or liver defects, which is
surprising because the three isoforms are highly expressed
in these organs (Saarela et al. 1998a, 1998b; present
study). Collagens XVIII and XV belong to the collagen
subfamily of multiplexins, with the highest degree of ho-
mology in the C-terminal endostatin domain. Collagen
XV is immunolocalized in an overlapping distribution
with collagen XVIII (Tomono et al. 2002), and mice
lacking collagen XV also do not exhibit abnormalities
in kidney and liver (instead, they show a mild myopathy)
(Eklund et al. 2001). Therefore, it is unlikely that col-
lagen XV plays a compensatory role in the absence of
collagen XVIII.
One of the patients (KS4) presented with recurrent
epilepsy (detected through electroencephalogram) and
thus was the second patient with KS to have this oc-
currence (Kliemann et al., in press), which had a re-
sultant frequency of 2 in 23 patients with seizures (21
patients from 6 families with a known pathogenic mu-
tation and 2 patients from the family reported by Klie-
mann et al. [in press]). Deficiency of the NC11 domain
of the cle-1 gene in C. elegans is associated with altered
axonal migration, and neuronal migration disorders
have recently been observed in two unrelated patients
with KS (Kliemann et al., in press). These preliminary
results suggest that deficiency of collagen XVIII iso-
forms may predispose individuals to epilepsy, possibly
because of abnormal neuronal migration.
In summary, the analysis of the 43 exons of the
COL18A1 gene confirms that mutations in this gene
lead to occipital encephalocele and severe ocular alter-
ations and suggests that both the NC11-303 and NC11-
728 isoforms of collagen XVIII play critical roles in the
maintenance and organization of the human eye. The
characterization of other patients with KS will be im-
portant to expand the preliminary genotype-phenotype
correlation suggested in this report, as well as to con-
firm the existence of a possible hotspot region in this
large molecule.
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